» Articles » PMID: 29094082

Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala

Overview
Journal J Glob Oncol
Specialty Oncology
Date 2017 Nov 3
PMID 29094082
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Cervical cancer rates in Latin America are higher than those in developed countries, likely because of the lower prevalence of screening. Specifically, less than 40% of women in Guatemala are regularly screened and even fewer women are screened in indigenous communities. Current screening strategies-Pap smears and visual inspection with acetic acid-might not be the most effective methods for controlling cancer in these settings. We thus investigated the potential of self-collection of cervical samples with testing for human papillomavirus (HPV) to help prevent cervical cancer in an indigenous community in Guatemala.

Patients And Methods: A community representative random sample of 202 indigenous women age 18 to 60 years residing in Santiago Atitlan, Guatemala, were surveyed to assess knowledge of and risk factors for HPV and cervical cancer. Women were then invited to self-collect a cervical sample using HerSwab collection kits to assess the prevalence of HPV and the acceptability of self-sampling.

Results: Of 202 women who completed the survey, 178 (89%) provided a self-sample. In all, 79% of these women found the test comfortable, 91% found the test easy to use, and 100% reported they were willing to perform the test periodically as a screening method. Thirty-one samples (17%) were positive for at least one of 13 high-risk HPV types, and eight (4.5%) were positive for HPV 16/18.

Conclusion: HPV testing by using self-collected samples was well accepted, suggesting that it is a plausible modality for cervical cancer screening in indigenous communities. Further studies are needed to assess rates of follow-up after a positive test and to determine whether these findings extend to other indigenous and nonindigenous communities in Guatemala and Latin America.

Citing Articles

Overcoming Cultural Barriers and Building Healthcare Trust: A Mixed Methods Study on Cervical Cancer Prevention Among Arab American Women Across Major U.S. Cities.

Khoja L, Zoulfikar M, Hak L, Yousif S, Aljebori M, Stiffler M Cancers (Basel). 2025; 17(1.

PMID: 39796637 PMC: 11718821. DOI: 10.3390/cancers17010005.


Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries: a scoping review of accuracy, acceptability, cost, uptake, and equity.

Otieno J, Were L, Nyanchoka M, Olwanda E, Mulaku M, Sem X Front Public Health. 2024; 12:1439164.

PMID: 39678248 PMC: 11638174. DOI: 10.3389/fpubh.2024.1439164.


Cervical precancer screening using self-sampling, HPV DNA testing, and mobile colposcopy in a hard-to-reach community in Ghana: a pilot study.

Effah K, Tekpor E, Wormenor C, Allotey J, Owusu-Agyeman Y, Kemawor S BMC Cancer. 2024; 24(1):1367.

PMID: 39516742 PMC: 11545337. DOI: 10.1186/s12885-024-13113-9.


Investigating under-reported human papillomavirus genotypes in Grenadian women through self-sampling for cervical cancer screening.

McGill F, Fields P, Bahadoor-Yetman A, Manglardi E, Bailey R, Padala K Rev Panam Salud Publica. 2024; 48:e62.

PMID: 39044773 PMC: 11265311. DOI: 10.26633/RPSP.2024.62.


Impact of the universal health insurance benefits on cervical cancer mortality in Colombia.

Lewis A, Hernandez D, Garces-Palacio I, Soliman A BMC Health Serv Res. 2024; 24(1):693.

PMID: 38822370 PMC: 11143589. DOI: 10.1186/s12913-024-10979-0.


References
1.
Valles X, Murga G, Hernandez G, Sabido M, Chuy A, Lloveras B . High prevalence of human papillomavirus infection in the female population of Guatemala. Int J Cancer. 2009; 125(5):1161-7. DOI: 10.1002/ijc.24444. View

2.
Luciani S, Cabanes A, Prieto-Lara E, Gawryszewski V . Cervical and female breast cancers in the Americas: current situation and opportunities for action. Bull World Health Organ. 2013; 91(9):640-9. PMC: 3790216. DOI: 10.2471/BLT.12.116699. View

3.
Adamson P, Huchko M, Moss A, Kinkel H, Medina-Marino A . Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa. PLoS One. 2015; 10(9):e0137299. PMC: 4557833. DOI: 10.1371/journal.pone.0137299. View

4.
Boggan J, Walmer D, Henderson G, Chakhtoura N, McCarthy S, Beauvais H . Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population. Sex Transm Dis. 2015; 42(11):655-9. PMC: 4610156. DOI: 10.1097/OLQ.0000000000000345. View

5.
Qiao Y, Sellors J, Eder P, Bao Y, Lim J, Zhao F . A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008; 9(10):929-36. DOI: 10.1016/S1470-2045(08)70210-9. View